Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Common respiratory conditions of the newborn.

Gallacher DJ, Hart K, Kotecha S.

Breathe (Sheff). 2016 Mar;12(1):30-42. doi: 10.1183/20734735.000716. Review.

2.

Antecedents of inflammation biomarkers in preterm newborns on days 21 and 28.

Leviton A, Allred EN, Fichorova RN, Kuban KC, O'Shea TM, Dammann O; ELGAN Study Investigators.

Acta Paediatr. 2016 Mar;105(3):274-80. doi: 10.1111/apa.13286. Epub 2015 Dec 23.

PMID:
26610180
3.

Genomic Insights into Respiratory Outcomes after Preterm Birth.

Abman SH, Mourani P, Wagner B.

Am J Respir Crit Care Med. 2015 Sep 1;192(5):530-2. doi: 10.1164/rccm.201506-1120ED. No abstract available.

PMID:
26325151
4.

Maternal high-fat diet is associated with impaired fetal lung development.

Mayor RS, Finch KE, Zehr J, Morselli E, Neinast MD, Frank AP, Hahner LD, Wang J, Rakheja D, Palmer BF, Rosenfeld CR, Savani RC, Clegg DJ.

Am J Physiol Lung Cell Mol Physiol. 2015 Aug 15;309(4):L360-8. doi: 10.1152/ajplung.00105.2015. Epub 2015 Jun 19.

PMID:
26092997
5.

Systems approach to the study of brain damage in the very preterm newborn.

Leviton A, Gressens P, Wolkenhauer O, Dammann O.

Front Syst Neurosci. 2015 Apr 14;9:58. doi: 10.3389/fnsys.2015.00058. eCollection 2015.

6.

Bronchopulmonary dysplasia early changes leading to long-term consequences.

Hilgendorff A, O'Reilly MA.

Front Med (Lausanne). 2015 Feb 12;2:2. doi: 10.3389/fmed.2015.00002. eCollection 2015. Review.

7.

A study of genes encoding cytokines (IL6, IL10, TNF), cytokine receptors (IL6R, IL6ST), and glucocorticoid receptor (NR3C1) and susceptibility to bronchopulmonary dysplasia.

Huusko JM, Karjalainen MK, Mahlman M, Haataja R, Kari MA, Andersson S, Toldi G, Tammela O, Rämet M, Lavoie PM, Hallman M; Gen-BPD Study Group.

BMC Med Genet. 2014 Nov 1;15:120. doi: 10.1186/s12881-014-0120-7.

8.

Maternal protein restriction alters VEGF signaling and decreases pulmonary alveolar in fetal rats.

Liu X, Lin Y, Tian B, Miao J, Xi C, Liu C.

Int J Clin Exp Pathol. 2014 May 15;7(6):3101-11. eCollection 2014.

9.

Reducing the incidence of chronic lung disease in very premature infants with aminophylline.

Armanian AM, Badiee Z, Afghari R, Salehimehr N, Hassanzade A, Sheikhzadeh S, Shariftehrani M, Rezvan G.

Int J Prev Med. 2014 May;5(5):569-76.

10.

Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension.

Mestan KK, Check J, Minturn L, Yallapragada S, Farrow KN, Liu X, Su E, Porta N, Gotteiner N, Ernst LM.

Placenta. 2014 Aug;35(8):570-4. doi: 10.1016/j.placenta.2014.05.003. Epub 2014 May 20.

11.

Change in practice after the Surfactant, Positive Pressure and Oxygenation Randomised Trial.

LeVan JM, Brion LP, Wrage LA, Gantz MG, Wyckoff MH, Sánchez PJ, Heyne R, Jaleel M, Finer NN, Carlo WA, Das A, Stoll BJ, Higgins RD; Eunice Kennedy Shriver NICHD Neonatal Research Network.

Arch Dis Child Fetal Neonatal Ed. 2014 Sep;99(5):F386-90. doi: 10.1136/archdischild-2014-306057. Epub 2014 May 29.

12.

Developmental determinants and changing patterns of respiratory outcomes after preterm birth.

Abman SH, Conway SJ.

Birth Defects Res A Clin Mol Teratol. 2014 Mar;100(3):127-33. doi: 10.1002/bdra.23242. No abstract available. Erratum in: Birth Defects Res A Clin Mol Teratol. 2014 Oct;100(10):811.

13.

Preeclampsia and the risk of bronchopulmonary dysplasia in VLBW infants: a population based study.

Yen TA, Yang HI, Hsieh WS, Chou HC, Chen CY, Tsou KI, Tsao PN; Taiwan Premature Infant Developmental Collaborative Study Group.

PLoS One. 2013 Sep 20;8(9):e75168. doi: 10.1371/journal.pone.0075168. eCollection 2013.

14.

Leptin promotes fetal lung maturity and upregulates SP-A expression in pulmonary alveoli type-II epithelial cells involving TTF-1 activation.

Chen H, Zhang JP, Huang H, Wang ZH, Cheng R, Cai WB.

PLoS One. 2013 Jul 22;8(7):e69297. doi: 10.1371/journal.pone.0069297. Print 2013.

15.

Postnatal weight gain in preterm infants with severe bronchopulmonary dysplasia.

Natarajan G, Johnson YR, Brozanski B, Farrow KN, Zaniletti I, Padula MA, Asselin JM, Durand DJ, Short BL, Pallotto EK, Dykes FD, Reber KM, Evans JR, Murthy K; Children's Hospital Neonatal Consortium Executive Board and Study Group.

Am J Perinatol. 2014 Mar;31(3):223-30. doi: 10.1055/s-0033-1345264. Epub 2013 May 20.

16.

Ureaplasma and BPD.

Kallapur SG, Kramer BW, Jobe AH.

Semin Perinatol. 2013 Apr;37(2):94-101. doi: 10.1053/j.semperi.2013.01.005. Review.

17.

Intrauterine growth restriction transiently delays alveolar formation and disrupts retinoic acid receptor expression in the lung of female rat pups.

Joss-Moore L, Carroll T, Yang Y, Fitzhugh M, Metcalfe D, Oman J, Hale M, Dong L, Wang ZM, Yu X, Callaway CW, O'Brien E, McKnight RA, Lane RH, Albertine KH.

Pediatr Res. 2013 May;73(5):612-20. doi: 10.1038/pr.2013.38. Epub 2013 Feb 18.

18.

Chorioamnionitis and lung injury in preterm newborns.

Rocha G.

Crit Care Res Pract. 2013;2013:890987. doi: 10.1155/2013/890987. Epub 2013 Jan 10.

19.

Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia.

Check J, Gotteiner N, Liu X, Su E, Porta N, Steinhorn R, Mestan KK.

J Perinatol. 2013 Jul;33(7):553-7. doi: 10.1038/jp.2012.164. Epub 2013 Jan 17.

20.

Predictors of bronchopulmonary dysplasia.

Trembath A, Laughon MM.

Clin Perinatol. 2012 Sep;39(3):585-601. doi: 10.1016/j.clp.2012.06.014. Review.

Items per page

Supplemental Content

Write to the Help Desk